Motley Fool Asset Management LLC increased its position in CME Group Inc (NASDAQ:CME) by 24.9% in the first quarter, HoldingsChannel.com reports. The firm owned 5,657 shares of the financial services provider’s stock after acquiring an additional 1,126 shares during the period. Motley Fool Asset Management LLC’s holdings in CME Group were worth $931,000 at the end of the most recent quarter.
A number of other hedge funds have also recently made changes to their positions in the stock. Morgan Stanley grew its stake in CME Group by 20.5% during the 3rd quarter. Morgan Stanley now owns 1,118,708 shares of the financial services provider’s stock valued at $190,415,000 after acquiring an additional 190,256 shares in the last quarter. Contravisory Investment Management Inc. grew its stake in CME Group by 197.6% during the 4th quarter. Contravisory Investment Management Inc. now owns 253 shares of the financial services provider’s stock valued at $48,000 after acquiring an additional 168 shares in the last quarter. Gateway Investment Advisers LLC grew its stake in CME Group by 3.8% during the 4th quarter. Gateway Investment Advisers LLC now owns 48,696 shares of the financial services provider’s stock valued at $9,161,000 after acquiring an additional 1,785 shares in the last quarter. DNB Asset Management AS grew its stake in CME Group by 5.3% during the 4th quarter. DNB Asset Management AS now owns 44,694 shares of the financial services provider’s stock valued at $8,408,000 after acquiring an additional 2,261 shares in the last quarter. Finally, Ipswich Investment Management Co. Inc. purchased a new stake in CME Group during the 4th quarter valued at about $47,000. Hedge funds and other institutional investors own 84.78% of the company’s stock.
CME Group stock opened at $183.32 on Friday. CME Group Inc has a 1-year low of $157.21 and a 1-year high of $197.08. The company has a debt-to-equity ratio of 0.16, a current ratio of 1.04 and a quick ratio of 1.04. The company has a market capitalization of $65.59 billion, a PE ratio of 26.88, a PEG ratio of 4.16 and a beta of 0.32.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 25th. Stockholders of record on Monday, June 10th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Friday, June 7th. This represents a $3.00 annualized dividend and a dividend yield of 1.64%. CME Group’s dividend payout ratio is currently 43.99%.
In other news, Director Jeffrey M. Bernacchi sold 10,087 shares of the company’s stock in a transaction that occurred on Tuesday, February 26th. The shares were sold at an average price of $177.94, for a total value of $1,794,880.78. Following the transaction, the director now directly owns 42,004 shares in the company, valued at approximately $7,474,191.76. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO John W. Pietrowicz sold 2,500 shares of the company’s stock in a transaction that occurred on Wednesday, April 3rd. The stock was sold at an average price of $168.27, for a total transaction of $420,675.00. Following the completion of the transaction, the chief financial officer now owns 35,354 shares in the company, valued at $5,949,017.58. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 38,489 shares of company stock worth $6,739,196. Company insiders own 1.20% of the company’s stock.
Several analysts have recently weighed in on the stock. BidaskClub raised shares of CME Group from a “hold” rating to a “buy” rating in a research note on Tuesday. ValuEngine raised shares of CME Group from a “hold” rating to a “buy” rating in a research note on Wednesday, May 8th. JPMorgan Chase & Co. assumed coverage on shares of CME Group in a research note on Friday, February 15th. They issued an “underweight” rating and a $164.00 price target for the company. Sanford C. Bernstein reissued an “outperform” rating and issued a $210.00 price target on shares of CME Group in a research note on Friday, February 15th. Finally, Rosenblatt Securities cut shares of CME Group from a “neutral” rating to a “sell” rating in a research note on Thursday, April 18th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and eight have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $189.71.
WARNING: “Motley Fool Asset Management LLC Increases Position in CME Group Inc (CME)” was originally published by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this article on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this article can be accessed at https://www.baseballdailydigest.com/news/2019/05/17/motley-fool-asset-management-llc-increases-position-in-cme-group-inc-cme.html.
About CME Group
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Article: Stock Selection – What is cash flow?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.